• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑人和白人难治性高血压患者中的醛固酮增多症。

Hyperaldosteronism among black and white subjects with resistant hypertension.

作者信息

Calhoun David A, Nishizaka Mari K, Zaman Mohammad A, Thakkar Roopal B, Weissmann Paula

机构信息

Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Ala, USA.

出版信息

Hypertension. 2002 Dec;40(6):892-6. doi: 10.1161/01.hyp.0000040261.30455.b6.

DOI:10.1161/01.hyp.0000040261.30455.b6
PMID:12468575
Abstract

Recent reports suggesting that the prevalence of primary hyperaldosteronism may be higher than historically thought have relied on an elevated plasma aldosterone concentration/plasma renin activity ratio to either diagnose or identify subjects at high risk of having primary hyperaldosteronism and have not included suppression testing of all evaluated subjects. In this prospective study of 88 consecutive patients referred to a university clinic for resistant hypertension, we determined the 24-hour urinary aldosterone excretion during high dietary salt ingestion, baseline plasma renin activity, and plasma aldosterone in all subjects. Primary hyperaldosteronism was confirmed if plasma renin activity was <1.0 ng/mL per hour and urinary aldosterone was >12 microg/24-hour during high urinary sodium excretion (>200 mEq/24-hour). Eighteen subjects (20%) were confirmed to have primary hyperaldosteronism. The prevalence of hyperaldosteronism was similar in black and white subjects. Of the 14 subjects with confirmed hyperaldosteronism who have been treated with spironolactone, all have manifested a significant reduction in blood pressure. In this population, an elevated plasma aldosterone/plasma renin activity ratio (>20) had a sensitivity of 89% and a specificity of 71% with a corresponding positive predictive value of 44% and a negative predictive value of 96%. These data provide strong evidence that hyperaldosteronism is a common cause of resistant hypertension in black and white subjects. The accuracy of these results is strengthened by having done suppression testing of all evaluated subjects.

摘要

最近的报告表明,原发性醛固酮增多症的患病率可能高于以往的认识,这些报告依据血浆醛固酮浓度/血浆肾素活性比值升高来诊断或识别原发性醛固酮增多症的高危人群,且并未对所有评估对象进行抑制试验。在这项针对88例连续转诊至大学诊所治疗顽固性高血压患者的前瞻性研究中,我们测定了所有对象在高盐饮食摄入期间的24小时尿醛固酮排泄量、基线血浆肾素活性和血浆醛固酮水平。如果在高尿钠排泄(>200 mEq/24小时)期间血浆肾素活性<1.0 ng/mL per小时且尿醛固酮>12 μg/24小时,则确诊为原发性醛固酮增多症。18名对象(20%)被确诊患有原发性醛固酮增多症。醛固酮增多症在黑人和白人对象中的患病率相似。在14例已接受螺内酯治疗的确诊醛固酮增多症对象中,所有人的血压均显著降低。在该人群中,血浆醛固酮/血浆肾素活性比值升高(>20)的敏感性为89%,特异性为71%,相应的阳性预测值为44%,阴性预测值为96%。这些数据提供了有力证据,表明醛固酮增多症是黑人和白人顽固性高血压的常见病因。对所有评估对象进行抑制试验增强了这些结果的准确性。

相似文献

1
Hyperaldosteronism among black and white subjects with resistant hypertension.黑人和白人难治性高血压患者中的醛固酮增多症。
Hypertension. 2002 Dec;40(6):892-6. doi: 10.1161/01.hyp.0000040261.30455.b6.
2
Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.非洲裔美国人和白人难治性高血压患者血浆醛固酮与肾素活性比值的有效性
Am J Hypertens. 2005 Jun;18(6):805-12. doi: 10.1016/j.amjhyper.2005.01.002.
3
Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.通过醛固酮/肾素比值及螺内酯试验评估原发性醛固酮增多症的患病率。
Clin Med (Lond). 2005 Jan-Feb;5(1):55-60. doi: 10.7861/clinmedicine.5-1-55.
4
Normokalemic hyperaldosteronism in patients with resistant hypertension.顽固性高血压患者的正常血钾性醛固酮增多症
Isr Med Assoc J. 2002 Jan;4(1):17-20.
5
Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO.血清醛固酮与血浆肾素活性比值能否预测利尿剂在高血压中的疗效?RENALDO 研究结果。
J Hypertens. 2010 Jan;28(1):170-7. doi: 10.1097/HJH.0b013e328332b79b.
6
Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.醛固酮增多症高血压患者内皮依赖性血流介导的血管舒张功能受损。
Circulation. 2004 Jun 15;109(23):2857-61. doi: 10.1161/01.CIR.0000129307.26791.8E. Epub 2004 Jun 1.
7
Hyperaldosteronism and hypertension: ethnic differences.醛固酮增多症与高血压:种族差异
Hypertension. 2005 Apr;45(4):766-72. doi: 10.1161/01.HYP.0000154364.00763.d5. Epub 2005 Feb 7.
8
Lessons from Africa: the importance of measuring plasma renin and aldosterone in resistant hypertension.非洲的经验教训:测定血浆肾素和醛固酮在顽固性高血压中的重要性。
Can J Cardiol. 2012 May;28(3):254-7. doi: 10.1016/j.cjca.2011.11.010. Epub 2012 Jan 29.
9
[Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].[原发性醛固酮增多症及低肾素、正常肾素和高肾素型高血压患者的直肠电位差与血浆醛固酮]
Wien Klin Wochenschr. 1976 Dec 10;88(23):777-81.
10
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.原发性醛固酮增多症在顽固性高血压中的患病率:一项回顾性观察研究。
Lancet. 2008 Jun 7;371(9628):1921-6. doi: 10.1016/S0140-6736(08)60834-X.

引用本文的文献

1
Baxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24.用于治疗难治性高血压的巴多司他:3期临床试验BaxHTN、BaxAsia和Bax24的原理与设计
Hypertens Res. 2025 Aug 25. doi: 10.1038/s41440-025-02297-7.
2
A predictive nomogram for incomplete clinical success after unilateral adrenalectomy in patients with primary aldosteronism.原发性醛固酮增多症患者单侧肾上腺切除术后不完全临床成功的预测列线图。
Front Endocrinol (Lausanne). 2025 Jul 24;16:1628564. doi: 10.3389/fendo.2025.1628564. eCollection 2025.
3
Indications for primary aldosteronism screening in people with hypertension and hyperparathyroidism: a multi-centre cohort study.
高血压和甲状旁腺功能亢进患者原发性醛固酮增多症筛查的指征:一项多中心队列研究
Endocrine. 2025 Jul 3. doi: 10.1007/s12020-025-04323-7.
4
Hypertension in Sub-Saharan Africa: Burden, Barriers and Priorities for Improving Treatment Outcomes.撒哈拉以南非洲地区的高血压:负担、障碍及改善治疗效果的优先事项
Circ Res. 2025 Jun 20;137(1):106-118. doi: 10.1161/CIRCRESAHA.124.323889. Epub 2025 Jun 19.
5
A case of simultaneous adrenalectomy and dissection repair with direct sheath placement into the aorta and systematic review of cases with hyperaldosteronism and vascular dissection: a case report.一例同时进行肾上腺切除术及直接将鞘膜置于主动脉的夹层修复术并对醛固酮增多症合并血管夹层病例进行系统回顾:病例报告
J Med Case Rep. 2025 May 19;19(1):237. doi: 10.1186/s13256-025-05276-1.
6
Low-dose Spironolactone Combined with ACEIs/ARBs May Reduce Cardiovascular Events in Patients with CKD Stages 3b-5: A Nationwide Population-Based Cohort Study in Taiwan.低剂量螺内酯联合ACEIs/ARBs可能降低3b-5期慢性肾脏病患者的心血管事件:台湾一项基于全国人群的队列研究
Int J Med Sci. 2025 Feb 24;22(6):1404-1414. doi: 10.7150/ijms.103390. eCollection 2025.
7
Advancements in the research of the structure, function, and disease-related roles of ARMC5.ARMC5的结构、功能及与疾病相关作用的研究进展
Front Med. 2025 Apr;19(2):185-199. doi: 10.1007/s11684-024-1108-0. Epub 2025 Feb 17.
8
High prevalence of primary aldosteronism in a tertiary care hospital in Lebanon.黎巴嫩一家三级护理医院原发性醛固酮增多症的高患病率。
Medicine (Baltimore). 2025 Feb 7;104(6):e41384. doi: 10.1097/MD.0000000000041384.
9
Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights.原发性醛固酮增多症的范式转变:通过整合病理生理学见解重新考虑筛查策略
Front Endocrinol (Lausanne). 2025 Jan 14;15:1372683. doi: 10.3389/fendo.2024.1372683. eCollection 2024.
10
Screening of primary aldosteronism and pheochromocytoma among patients with hypertension: an Italian nationwide survey.高血压患者中原发性醛固酮增多症和嗜铬细胞瘤的筛查:一项意大利全国性调查。
J Endocrinol Invest. 2025 May;48(5):1197-1205. doi: 10.1007/s40618-025-02532-5. Epub 2025 Jan 18.